Amerise Biosciences Ltd — Important, 06-04-2026: Company Update

Amerise Biosciences has submitted its compliance certificate for the quarter ended March 31, 2026, related to share dematerialization. This report, a routine regulatory filing, confirms adherence to rules ensuring smooth processing of physical shares into electronic form. Importantly, the company's Registrar and Share Transfer Agent certified that no physical share certificates were received for dematerialization during this quarter. This indicates a streamlined process and ongoing operational efficiency in managing investor share conversions.